A study involving ten European countries, including Switzerland, has been launched to better understand monkeypox. It will follow people affected by the disease, record their symptoms and study their response to treatment.
This content was published on
2 minutes
Keystone-SDA/ts
Español
es
Suiza recluta pacientes para estudio de la viruela del mono
The Geneva University Hospitals (HUG) said it had recruited its first three patients.
The study builds on ongoing work in the Central African Republic to better characterise the disease in countries where recent spread has been reported. For the moment Switzerland is the first country to recruit patients for the study. The aim is to extend it to as many countries as possible.
“Thanks to this unprecedented international collaboration, we will be able to contribute to a better understanding of the disease and thus to adjust our response in the fight against it,” said Alexandra Calmy, head of the HIV/AIDS Unit at the HUG.
At least 500 patients are expected to be included in the study, she added. To date, ten countries have announced their participation: Switzerland, the UK, Belgium, France, Ireland, Italy, the Netherlands, Norway, Portugal and Spain.
Rarely fatal
Monkeypox is a relatively rare disease. It usually causes a painful rash but is rarely fatal. It was discovered in the late 1950s, with outbreaks occurring in communities in central and western Africa. The disease is now spreading to Europe.
More than 50 countries where monkeypox is not endemic have reported outbreaks of the viral disease as confirmed cases exceed 7,600. Switzerland had 140 confirmed cases as of July 8.
In Switzerland, as elsewhere in Europe, the population most affected by the disease comprises young men who are involved in “dense sexual networks” and in particular who report having gay sex, Calmy said.
More
More
South Africa confirms third monkeypox case in tourist from Switzerland
This content was published on
South Africa has confirmed a third case of monkeypox, in a 42-year-old male tourist from Switzerland.
Top Swiss firms close to reaching gender quota in boards
This content was published on
The proportion of women on the boards of directors of the fifty largest listed companies in Switzerland currently stands at 28%.
Swiss committee wants to end government resignations during legislative term
This content was published on
Members of the Federal Council should no longer be able to leave office before the end of their term, according to a House of Representatives committee.
Swiss government seat: Ritter and Pfister nominated to succeed Amherd
This content was published on
Markus Ritter from St Gallen and Martin Pfister from Zug were officially nominated by the Centre Party on Friday to succeed Defence Minister Viola Amherd.
Top Swiss court rejects Russian request for administrative tax assistance
This content was published on
There is currently no reason to transmit banking information to the Russian Federation, the Swiss Federal Court has ruled.
After strike by radiologists, doctors demonstrate in Bern
This content was published on
Following a strike by radiology technicians in Fribourg, doctors, vets, dentists and chiropractors expressed their frustration on Friday outside parliament in the Swiss capital.
Eurovision and bleak world situation are top themes at Basel carnival
This content was published on
The Eurovision Song Contest and the gloomy global situation are among the main themes of Basel Fasnacht (carnival) this year.
Prices of Swiss investment properties continue to rise despite stagnating rents
This content was published on
Although rents in Switzerland stagnated or fell in the final quarter of last year, prices for investment properties continued to rise. Both apartment buildings and office properties have become more expensive.
Probe into wrong Swiss pension figures clears federal office
This content was published on
Employees of the Swiss Federal Social Insurance Office (FSIO) did not breach their duty of care when calculating pension prospects, an investigation has concluded.
This content was published on
The second case of monkeypox in Switzerland was detected in a person in Geneva, who was contaminated during a trip abroad.
Monkeypox medication not authorised in Switzerland
This content was published on
Tecovirimat and the latest smallpox vaccine, which help against monkeypox, are not available in Switzerland, the NZZ am Sonntag reports.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.